Campus Alert: Find the latest UMMS campus news and resources at umassmed.edu/coronavirus


Print

UMass research and development expenditures rise to record $684 million

UMass Medical School research expenditures up 2.7 percent

UMass Medical School Communications

June 19, 2020

Research expenditures at the University of Massachusetts increased by $33 million in one fiscal year to a record high of $684 million in fiscal year 2019. This continued increase reflects the long-term growth of the university's research enterprise, which has grown by 14 percent since FY14 and 40 percent since FY09. At UMass Medical School, research expenditures rose by 2.7 percent to $281.51 million.

Federal funding remained the largest source of research funding at UMass in FY19, with federally funded research comprising $383 million, or roughly 56 percent of all expenditures. While federal research growth has been relatively steady, growing six percent over five years, UMass has seen its industry- and non-profit-sponsored research grow by 43 percent over five years to its current total of $64,997,000 in FY19.

UMass is the fourth-largest research university in New England and the third-largest in Massachusetts.

Research at UMass is concentrated in areas that are critical to the Massachusetts economy, with $370 million, or 54.1 percent being conducted in the life sciences in FY19. In addition to the life sciences, UMass is focused on a wide variety of research areas that are aimed at bolstering local, regional and state-wide industries. These include manufacturing, renewable energy, climate resiliency, coastal preservation, commercial fishing and national defense.

“As a public land-grant university, UMass has a deeper responsibility to support the Commonwealth, its citizens and its economy,” said UMass President Marty Meehan, who was appointed to the Board of Directors of the Association for Public Land-grant Universities (APLU) in November. “A strong and diverse research ecosystem is central to our innovation economy and UMass is positioned to play a leading role in driving our economic recovery.”

In addition to pronounced growth in the quantity of overall research, UMass is also seeing significant growth in its intellectual property and technology transfer program. In FY19 alone, UMass, mostly via the Medical School, filed 206 invention disclosures, 203 patent applications and was issued 73 U.S. patents.

Over the past five years, UMass research has been the driving force behind:

  • 1178 invention disclosures
  • 1088 patent applications
  • 382 issued patents
  • $323 million in gross licensing revenue
  • 50 new spinoff companies

“The continued success of our intellectual property and commercialization program is a testament to the world-class faculty, researchers and students that we have at UMass,” President Meehan said.

Recent research highlights from UMass include:

For the full FY19 UMass research report, visit: www.umass.info/fy19-research-report.